More is Different

Share this post
The Case for Leronlimab
moreisdifferent.substack.com

The Case for Leronlimab

Dan Elton
May 1, 2021
2
Comment6

it's a weak case

Read →

Create your profile

0 subscriptions will be displayed on your profile (edit)

Skip for now

Only paid subscribers can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.

  • New First
  • Chronological
© 2022 Daniel C. Elton
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing